Supernus price target raised to $47 from $40 at Piper Sandler

Piper Sandler analyst David Amsellem raised the firm’s price target on Supernus to $47 from $40 and keeps an Overweight rating on the shares after meeting with management. The analyst continues to believe that as the footprint of Qelbree grows, the likelihood of execution on a major payer contract should grow. The firm now assigns a lower degree of commercial risk to Qelbree and sees an attractive risk/reward at current share levels.